Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study

Toru Arai, Masaki Hirose, Tomoko Kagawa, Naoko Takeuchi, Takehiko Kobayashi, Yoshikazu Inoue, Yoshinobu Matsuda

Open source

DOI
10.3390/jcm14227914
Published
2025-11-07
Container
Journal of Clinical Medicine
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm14227914,
  title = {Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study},
  author = {Toru Arai and Masaki Hirose and Tomoko Kagawa and Naoko Takeuchi and Takehiko Kobayashi and Yoshikazu Inoue and Yoshinobu Matsuda},
  year = {2025},
  journal = {Journal of Clinical Medicine},
  doi = {10.3390/jcm14227914},
  url = {https://doi.org/10.3390/jcm14227914}
}

RIS

TY  - JOUR
TI  - Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study
AU  - Toru Arai
AU  - Masaki Hirose
AU  - Tomoko Kagawa
AU  - Naoko Takeuchi
AU  - Takehiko Kobayashi
AU  - Yoshikazu Inoue
AU  - Yoshinobu Matsuda
PY  - 2025
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm14227914
UR  - https://doi.org/10.3390/jcm14227914
ER  - 

APA

Arai, T., Hirose, M., Kagawa, T., Takeuchi, N., Kobayashi, T., Inoue, Y., & Matsuda, Y. (2025). Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study. Journal of Clinical Medicine. https://doi.org/10.3390/jcm14227914

Source records